Events

Incoming events

February 2, 2021 CHOP Cell and Gene Therapy Clinical Training Program "Cell Based Gene Therapies: Non-malignant" (S. Rivella)

March 9, 2021 Hematopoietic Stem Cells: Biology, Disease, And Therapy Penn IRM (Institute for Regenerative Medicine): "Gene therapy using HSC: successes and challenges" (S. Rivella)

March 18-19, 2021 The Virtual Conference on Challenges in Hematology (C-Hem2021) "Gene Therapy for Hemoglobinopathies: Where We Stand" (S. Rivella)

June 9-17, 2021 EHA 2021 Congress SWG: Red cells and iron; Novel therapies in hemoglobin induction: "Gene therapy strategies to Express Curative Hemoglobins​" (S. Rivella)

July 31, August 1-6 2021 Cell Biology of Metals GRC/GRS "TBD" (S. Rivella)

October 6, 2021 CCEH Virtual Meet-the-Expert Seminar Series “Hemoglobinopathies, challenges and therapeutic approaches” (S. Rivella)

The Penn-CHOP Blood Center Seminar series; speakers invited by Dr. Rivella:

Caroline Philpott, PhD (NIH): "Mischief managed: chaperoning iron through cells and tissues"

Francesca Vinchi, PhD (NYBC) "Iron-mediated control of macrophage plasticity in health and disease"

Gregg L. Semenza, MD, PhD (Johns Hopkins University School of Medicine): “Oxygen and Erythropoiesis”.

Daniel Starczynowski, PhD, (Cincinnati Children’s Hospital)

Robert F. Paulson, PhD, (Penn State University)

Todd Evans, (Weill Cornell Medicine): “Epignetic reglation of embryonic hematopoiesis by TET proteins”

Janis Abkowit, MD, (University of Washington): “The pathophysiology of Diamond Blackfa Anemia (DBA) and myelodysplatic syndrom (MDS)”

Adam Goldfarb, MD, (University of Virginia School of Medicine)

James Palis, MD (University of Rochester Medical Center): "Making blood before a blood stem cell".

Saghi Ghaffari, MD (Icahn School of Medicine at Mount Sinai): "Mitochondria in the Regulation of Blood-Forming Stem and Progenitor Cells; a FOXO3 Perspective".

Amit Verma, MD: "Therapeutic targeting of Myelodysplastic syndromes".

Attended meetings and presentations

October 22-23, 2020 Red Cell Club Meeting (virtual)

October 15–16​, 2020 East to West iron Club (virtual)

June 11-14, 2020 EHA in Frankfurt (virtual)

May 12-15, 2020 ASGCT in Boston (virtual)

Dec 3-4, 2019 Sanofi iAward in Boston

Dec 7-10, 2019 ASH in San Diego

Nov 6-9, 2019 EHA-SWG Scientific Meeting on Red Cell & Iron in Madrid

Oct 24-24, 2019 E2W Iron Club in New York

Dec 3-7, 2016 58th ASH Annual Meeting in San Diego

Sept 13, 2017 Ospedale Pediatrico Meyer

May 7-11, 2017 IBIS/BioIron in Los Angeles

July 23-28, 2017 Gordon conference: Metals in Physiology and Disease in West Dover, VT

Febr 2-4, 2017 Red Cells and Iron - Scientific Working Group of the European Hematology Association (EHA) in Barcelona

Oct 25-26, 2017 EWIC in Cincinnati

Dec 9-12, 2017 ASH in Atlanta

Sept 13, 2017 Ospedale Pediatrico Meyer in Florence

May 7-11, 2017 IBIS/BioIron in Los Angeles

July 23-28, 2017 Gordon conference: Metals in Physiology and Disease in West Dover, VT

December 3-7, 2016 58th ASH Annual Meeting in San Diego

February 2-4, 2017 Red Cells and Iron - Scientific Working Group of the European Hematology Association (EHA) - Barcelona

Recent Publications

Publications

Breda L, Ghiaccio V, Tanaka N, Jarocha D, Ikawa Y, Abdulmalik O, Dong A, Casu C, Raabe TD, Shan X, Danet-Desnoyers GA, Doto AM, Everett J, Bushman FD, Radaelli E, Assenmacher CA, Tarrant JC, Hoepp N, Guzikowski V, Smith-Whitley K, Janet L. Kwiatkowski JL, Stefano Rivella S. Lentiviral vector ALS20 yields high hemoglobin levels with low genomic integrations for treatment of beta-globinopathies. Molecular Therapy, in press

Bou-Fakhredin R, Dia B, Ghadieh HE, Rivella S, Cappellini MD, Eid AA, Taher AT. CYP450 Mediates Reactive Oxygen Species Production in a Mouse Model of β-Thalassemia through an Increase in 20-HETE Activity. Int J Mol Sci. 2021 Jan 23;22(3):1106. PMID: 33498614